Sakura Sato

Sakura Sato

Auto-generated profile, based on publicly available information

Sakura Sato

Department of Allergy, Clinical Research Center for Allergy and Rheumatology NHO Sagamihara National Hospital Sagamihara Kanagawa Japan

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
SDStephanie Dramburg
Stephanie Dramburg
Christiane HilgerChristiane Hilger
Christiane Hilger
ASAlexandra F Figueira Santos
Alexandra F Figueira Santos
LVLeticia de las Vecillas
Leticia de las Vecillas
RARob C. Aalberse
Rob C. Aalberse
KHKarin Hoffmann-Sommergruber
Karin Hoffmann-Sommergruber
Since the discovery of immunoglobulin E (IgE) as a mediator of allergic diseases in 1967, our knowledge about the immunological mechanisms of IgE‐mediated allergies has remarkably increased. In addition to understanding the immune response and clinical symptoms, allergy diagnosis and management depend strongly on the precise identification of the elicitors of the IgE‐mediated allergic reaction. In the past four decades, innovations in bioscience and technology have facilitated the identification and production of well‐defined, highly pure molecules for component‐resolved diagnosis (CRD), allowing a personalized diagnosis and management of the allergic disease for individual patients. The first edition of the “EAACI Molecular Allergology User's Guide” (MAUG) in 2016 rapidly became a key reference for clinicians, scientists, and interested readers with a background in allergology, immunology, biology, and medicine. Nevertheless, the field of molecular allergology is moving fast, and after 6 years, a new EAACI Taskforce was established to provide an updated document. The Molecular Allergology User's Guide 2.0 summarizes state‐of‐the‐art information on allergen molecules, their clinical relevance, and their application in diagnostic algorithms for clinical practice. It is designed for both, clinicians and scientists, guiding health care professionals through the overwhelming list of different allergen molecules available for testing. Further, it provides diagnostic algorithms on the clinical relevance of allergenic molecules and gives an overview of their biology, the basic mechanisms of test formats, and the application of tests to measure allergen exposure.

11 April 2022 in World Allergy Organization Journal
Verified
Journal Article
Open access
MBMagnus P. Borres
Magnus P. Borres
SSSakura Sato
Sakura Sato
MEMotohiro Ebisawa
Motohiro Ebisawa
Tree nuts are a powerful and common source of food allergens that induce IgE-mediated allergic reactions. Health authorities endorse the intake of tree nuts because they are regarded as nutritious. Allergic reactions to nuts can lead to severe and occasionally lethal reactions. Allergies to tree nuts are observed worldwide and are found in up to 4.9% of people in unspecific populations.

3 January 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
YMYoko Miura
Yoko Miura
KNKen-Ichi Nagakura
Ken-Ichi Nagakura
MNMakoto Nishino
Makoto Nishino
MTMari Takei
Mari Takei
KTKyohei Takahashi
Kyohei Takahashi
NYNoriyuki Yanagida
Noriyuki Yanagida

1 September 2020 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
KNKen‐Ichi Nagakura
Ken‐Ichi Nagakura
SSSakura Sato
Sakura Sato
YMYoko Miura
Yoko Miura
MNMakoto Nishino
Makoto Nishino
KTKyohei Takahashi
Kyohei Takahashi
NYNoriyuki Yanagida
Noriyuki Yanagida
Background: Severe reactions may develop during cow's milk (CM) oral immunotherapy (OIT). We investigated the safety and efficacy of low‐dose OIT with heated milk (HM) or unheated milk (UM) in children with anaphylaxis.Methods: Children with symptom onset after ingestion of 3‐mL HM on a double‐blind, placebo‐controlled food challenge were randomly assigned to the HM (n = 17) or UM (n = 16) group. HM group ingested milk powder heated at 125°C for 30 seconds, whereas the UM group used UM. Patients were hospitalized for 5 days; the HM or UM was gradually increased to 3 mL/day; 3‐mL/day ingestion was continued at home. One year later, the patients underwent 2‐day consecutive 3‐ and 25‐mL HM‐oral food challenges (OFCs) after 2‐week avoidance.Results: At baseline, milk‐ and casein‐specific immunoglobulin E (IgE) levels were 56.0 and 51.4 kUA/L in the HM group, and 55.2 and 65.6 kUA/L in the UM group, respectively. One year later, 35% and 18% in the HM group and 50% and 31% in UM group passed the 3 and 25 mL OFCs, respectively. Rates of moderate or severe symptoms and respiratory symptoms per home dose were significantly lower in the HM than in the UM group (0.7% and 1.2% vs 1.4% and 2.6%, respectively, P < .001). β‐lactoglobulin‐specific IgG4 levels significantly increased from baseline only in the UM group, whereas casein‐specific IgG4 levels significantly increased from baseline in both groups.Conclusions: HM‐OIT induced immunological changes more safely than the UM‐OIT. The possibility of lower treatment efficacy with HM‐OIT needs to be evaluated in larger studies.

1 October 2019 in Allergology International
Verified
Journal Article
Open access
TMTetsuharu Manabe
Tetsuharu Manabe
SSSakura Sato
Sakura Sato
NYNoriyuki Yanagida
Noriyuki Yanagida
NHNoriko Hayashi
Noriko Hayashi
MNMakoto Nishino
Makoto Nishino
MEMotohiro Ebisawa
Motohiro Ebisawa

1 March 2016 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
NMNobuyuki Maruyama
Nobuyuki Maruyama
SSSakura Sato
Sakura Sato
NYNoriyuki Yanagida
Noriyuki Yanagida
CCCerrone Cabanos
Cerrone Cabanos
KIKomei Ito
Komei Ito
MEMotohiro Ebisawa
Motohiro Ebisawa